Product Images Estarylla

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Estarylla NDC 70700-119 by Xiromed, Llc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chart

chart

This text describes different methods of birth control and the number of pregnancies per 100 women in a year for each method. It includes information about hormonal contraceptives such as birth control pills, skin patches, and vaginal rings, as well as non-hormonal methods such as condoms, diaphragms, and spermicides. It also mentions long-acting methods such as injections, intrauterine devices, and sterilization. Finally, it suggests natural methods such as avoiding sex during the most fertile days of the monthly cycle or using the withdrawal method.*

estarylla-blister - estarylla blister

estarylla-blister - estarylla blister

estarylla-carton - estarylla carton

estarylla-carton - estarylla carton

This is a prescription information for Estarylla tablet. It contains 21 blue and 7 green tablets which have to be taken one after the other for 28 days. The dosage must be taken as per the prescribed schedule. The package contains three units of blister cards each having 28 tablets. The prescription also includes essential details like the manufacturer, dosage, and ingredients of the tablet.*

figure 2

figure 2

This appears to be a list of studies focused on women's contraceptive use, including the year of the study, whether it focused on ever use or current use, and the corresponding Effect Estimate expressed as OR/RR. However, there is not enough context to provide any additional information or meaningful interpretation of the results.*

structure ee

structure ee

Ethinyl Estradiol is a synthetic estrogen used in combination with progestin as an oral contraceptive. It prevents ovulation by inhibiting the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus and therefore prevents the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. This hormone is also used for the treatment of postmenopausal osteoporosis, prostate cancer, and breast cancer.*

structure norgestimate

structure norgestimate

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.